Is CHE a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

148 people get CHE articles and Market Currents by email alert.

Get email alerts on CHE »

HEADLINES:

Chemed's CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)
Wed, May 22
Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend

Business Wire (Mon, 1:58PM)
Chemed Corporation to Present at the UBS Global Healthcare Conference

Business Wire (May 14, 2013)
Chemed Corporation to Present at JMP Securities Research Conference

Business Wire (May 6, 2013)
Chemed Corporation Announces Receipt of False Claims Action Complaint

Business Wire (May 3, 2013)
Chemed's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Fri, Apr 19 • 1 Comment
Chemed Reports First-Quarter 2013 Results

Business Wire (Apr 18, 2013)
Chemed To Report First-Quarter 2013 Earnings April 18, Related Conference Call To Be Held On April 19

Business Wire (Apr 5, 2013)
Chemed Management Presents at 2013 Barclays Global Healthcare Conference (Transcript)
Wed, Mar 13
Chemed Corporation to Present at the Barclays Global Healthcare Conference

Business Wire (Mar 6, 2013)
Chemed Corporation to Present at the RBC Capital Markets’ Healthcare Conference

Business Wire (Feb 21, 2013)
Chemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase – Declares Quarterly Dividend of 18 Cents

Business Wire (Feb 20, 2013)
Chemed's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 19
Chemed Reports Fourth-Quarter 2012 Results

Business Wire (Feb 18, 2013)
Chemed To Report Fourth-Quarter 2012 Earnings February 18, Related Conference Call To Be Held On February 19

Business Wire (Jan 31, 2013)
Chemed Corporation: Fundamental Stock Research Analysis
F.A.S.T. Graphs • Tue, Jan 29 • 5 Comments
Healthcare Check-Up: An Easy Portfolio For The New Paradigm
The Amalgamator • Mon, Jan 28 • 10 Comments
Chemed Corporation Announces a Five-Year $350 Million Amended and Restated Credit Agreement

Business Wire (Jan 22, 2013)
Chemed Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire (Jan 2, 2013)
Chemed Corporation to Present at the Oppenheimer 23rd Annual Healthcare Conference

Business Wire (Dec 6, 2012)

To learn more about Seeking Alpha Pro, click here.

Chemed Corporation: Fundamental Stock Research Analysis
F.A.S.T. Graphs • Tue, Jan 29 • 5 Comments
Chemed Urges Stockholders to Ignore Millbrook Capital
Todd Walker • Mon, May 18, 2009
Chemed Corporation: A Weird Mix with Good Prospects
Paul Price • Thu, Apr 23, 2009 • 2 Comments
Chemed Corporation Showing Strong Growth
Zacks Investment Research • Fri, Nov 28, 2008
Chemed Corporation: 2 Industry Leading Businesses at 1 Low Price
Paul Price • Tue, Apr 29, 2008 • 4 Comments
Chemed Corp.: Major Player in Hospice and Plumbing
Zacks Investment Research • Mon, Feb 26, 2007

Healthcare Check-Up: An Easy Portfolio For The New Paradigm
The Amalgamator • Mon, Jan 28 • 10 Comments
World Demographics: Embracing The Gracious Aging World
Nick Chiu • Fri, Nov 16, 2012 • 15 Comments
7 Undervalued Small Caps Pulling In Big Profits
ZetaKap • Tue, Aug 28, 2012 • 1 Comment
Choose CRAP Stocks For Investment Success
MagicDiligence • Wed, Apr 4, 2012 • 1 Comment
16 Healthcare Stocks With Impressive Profitability
Kapitall • Tue, Mar 27, 2012 • 1 Comment
A-Rated Dividend Stocks With High Earnings Yield
Greg Group • Tue, Mar 20, 2012 • 1 Comment
3 Healthcare Dividend Stocks Undervalued By Levered Free Cash Flows
Kapitall • Thu, Mar 1, 2012 • 1 Comment
15 Healthcare Stocks With Impressive Profitability
Kapitall • Thu, Dec 15, 2011 • 1 Comment
15 Small-Cap Rockets In An Unexpected Sector
Kurtis Hemmerling • Sun, Dec 11, 2011
18 Most Undervalued Healthcare Stocks
Kapitall • Fri, Dec 9, 2011 • 1 Comment
My Favorite Growth-At-A-Reasonable-Price Stock Screen
Efficient Alpha • Thu, Oct 20, 2011 • 3 Comments
4 Healthcare Dividend Stocks With Impressive Profitability
Kapitall • Mon, Sep 19, 2011
5 Healthcare Dividend Stocks Being Bought By Smart Money
Kapitall • Wed, Sep 7, 2011
9 Dividend Stocks Raising Their Yield on Cost
Dividends4Life • Fri, Aug 12, 2011 • 8 Comments
Momentum Ideas: 6 Rallying Healthcare Stocks With Conservative Accounting Practices
Kapitall • Thu, May 5, 2011
7 Companies With Conservative Accounting Practices Raising Earnings Guidance
Kapitall • Wed, Apr 13, 2011 • 1 Comment
Momentum Ideas: 12 Low Debt Stocks Approaching 52-Week Highs
Kapitall • Thu, Feb 24, 2011 • 1 Comment
11 Buyback Stocks With Conservative Accounting Practices
Kapitall • Fri, Feb 4, 2011 • 1 Comment
Contrarian Ideas: 20 Healthcare Stocks With Low Put/Call Ratios
Kapitall • Tue, Jan 18, 2011 • 1 Comment
20 Historically Profitable Companies Hitting New Highs
Kapitall • Wed, Dec 29, 2010 • 1 Comment

Chemed's CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)
Wed, May 22
Chemed's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Fri, Apr 19 • 1 Comment
Chemed Management Presents at 2013 Barclays Global Healthcare Conference (Transcript)
Wed, Mar 13
Chemed's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Tue, Feb 19
Chemed Corporation Q4 2008 Earnings Call Transcript
Tue, Feb 17, 2009
Chemed Corporation, Q3 2008 Earnings Call Transcript
Wed, Oct 22, 2008
Chemed Corporation Q2 2008 Earnings Call Transcript
Tue, Jul 29, 2008
CHEMED Corporation Q1 2008 Earnings Call Transcript
Mon, May 19, 2008
Chemed Corporation Q4 2007 Earnings Call Transcript
Fri, Feb 22, 2008

Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend

Business Wire (Mon, 1:58PM)
Chemed Corporation to Present at the UBS Global Healthcare Conference

Business Wire (May 14, 2013)
Chemed Corporation to Present at JMP Securities Research Conference

Business Wire (May 6, 2013)
Movers & Shakers: Friday’s movers: Regeneron, LinkedIn

at MarketWatch.com (May 3, 2013)
Chemed Corporation Announces Receipt of False Claims Action Complaint

Business Wire (May 3, 2013)
Chemed Reports First-Quarter 2013 Results

Business Wire (Apr 18, 2013)
Chemed To Report First-Quarter 2013 Earnings April 18, Related Conference Call To Be Held On April 19

Business Wire (Apr 5, 2013)
Chemed Corporation to Present at the Barclays Global Healthcare Conference

Business Wire (Mar 6, 2013)
Chemed Corporation to Present at the RBC Capital Markets’ Healthcare Conference

Business Wire (Feb 21, 2013)
Chemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase – Declares Quarterly Dividend of 18 Cents

Business Wire (Feb 20, 2013)
Chemed Reports Fourth-Quarter 2012 Results

Business Wire (Feb 18, 2013)
Chemed To Report Fourth-Quarter 2012 Earnings February 18, Related Conference Call To Be Held On February 19

Business Wire (Jan 31, 2013)
Chemed Corporation Announces a Five-Year $350 Million Amended and Restated Credit Agreement

Business Wire (Jan 22, 2013)
Chemed Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire (Jan 2, 2013)
Chemed Corporation to Present at the Oppenheimer 23rd Annual Healthcare Conference

Business Wire (Dec 6, 2012)
Chemed Corporation Declares Quarterly Dividend of 18 Cents

Business Wire (Nov 9, 2012)
Chemed Corporation to Present at the 2012 Credit Suisse Healthcare Conference

Business Wire (Nov 7, 2012)
Chemed Reports Third-Quarter 2012 Results

Business Wire (Oct 29, 2012)
Chemed To Report Third-Quarter 2012 Earnings October 29, Related Conference Call To Be Held On October 30

Business Wire (Oct 10, 2012)
Lightning Round: BP, Impax Labs & More

at CNBC.com (Oct 4, 2012)

CHE vs. ETF Alternatives

Company Description

Currently, there's no company description for CHE.

Sector: Healthcare

Industry: Home Health Care

Country: Russia

All
| Earnings
| Dividends
| M&A
| On the move

Monday, May 20, 4:58 PM Chemed (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.05%. For shareholders of record May 30. Payable June 19. Ex-div date May 28. (PR) Comment! [Dividends]
Friday, May 10, 2:00 PM Chemed (CHE -5.3%) takes a hit from a negative Citron Research report calling it 'Game Over' for the shares. Citron says that the recent False Claims suit filed against the company's VITAS business units is just the tip of the spear. Not only has the analyst community overlooked a second, equally damaging suit that was filed, but the government's takeover of the investigation means a potential trebling of damages against the company. Comment! [Healthcare, On the Move]
Friday, May 3, 9:27 AM Chemed (CHE) -16.2% premarket after the U.S. sues the hospice chain and several of its subsidiaries, alleging they submitted false Medicare billings for services that misspent "tens of millions of taxpayer dollars." In one instance cited by the government, CHE subsidiary Vitas Hospice billed a patient for care he didn't need and at a time when he was actually playing bingo. Comment! [Healthcare, On the Move]
Friday, May 3, 9:10 AM Premarket gainers: PKT +32%. YRCW +27%. INVN +18%. YY +8%. DDD +5%.
Losers: VCRA -35%. ZAGG -24%. GUID -23%. CHE -16%. ARNA -13%. CETV -13%. HMY -9%. LNKD -9%. AGNC -6%. RBS -6%. 3 Comments [On the Move]
Thursday, April 18, 4:33 PM Chemed (CHE): Q1 EPS of $1.38 beats by $0.08. Revenue of $367M (+3.9% Y/Y) beats by $1.92M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, February 20, 3:50 PM Chemed Corporation (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 0.92%. For shareholders of record Mar. 04. Payable Mar. 22. Ex-div date Feb. 28. (PR) Comment! [Dividends]
Sunday, November 11, 2012, 3:52 AM Chemed Corp (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.11%. For shareholders of record Nov. 19. Payable Dec. 10. Ex-div Nov. 15. (PR) Comment! [Dividends]
Friday, November 2, 2012, 10:38 AM Chemed (CHE -3%) discloses in a regulatory filing that in July it received an investigative subpoena from the Florida Attorney General seeking a variety of documents - of which it had previously produced in the course of prior government investigations - regarding billing records and procedures, patient eligibility for hospice care, plus other matters pertaining to its general business operations. 2 Comments [Healthcare, On the Move]
Monday, October 29, 2012, 2:12 PM Chemed (CHE): Q3 EPS of $1.28 misses by $0.07. Revenue of $354M (+3.8% Y/Y) misses by $6M. (PR) Comment! [Earnings, Healthcare]
Friday, August 3, 2012, 2:27 PM Chemed (CHE) declares $0.18/share quarterly dividend, 12.5% increase from prior dividend of $0.16. Forward yield 1.05%. For shareholders of record Aug 13. Payable Sep 04. Ex-div date Aug 09. (PR) Comment! [Dividends]
Wednesday, July 25, 2012, 4:59 PM Chemed (CHE): Q2 EPS of $1.26 in-line. Revenue of $354.2M (+6.2% Y/Y) beats by $0.59M. (PR) Comment! [Earnings, Healthcare]
Friday, April 20, 2012, 12:55 PM Chemed (CHE -4.9%) dips after posting a mixed Q1, beating on revenue but coming up short on its EPS. Net earnings actually rose 13% on better growth in its hospice-care segment, but margins were pressured by sales declines in its Roto-Rooter business. The company also lowered the top end of its EPS estimate by a nickel, now expecting to earn between $5.35 - $5.50 per share. Comment! [On the Move, Earnings]
Wednesday, February 15, 2012, 10:58 AM Chemed (CHE +3.9%) moves higher despite missing estimates on its Q4 report yesterday. Net income rose 14% Y/Y, weathering a drop in operating income from its Vitas hospice unit as its Roto-Rooter plumbing business offset the decline with a 28% jump in profit. The company also raises FY12 guidance, now expecting to earn $5.35 - $5.55 per share, above Street expectations of $5.27. 1 Comment [On the Move]
Tuesday, February 14, 2012, 4:51 PM Chemed (CHE): Q4 EPS of $1.45 may not be comaparable to consensus of $1.48. Revenue of $350M (+4.2% Y/Y) in-line. (PR) 3 Comments [Earnings, Healthcare]
Thursday, January 5, 2012, 12:31 PM A Bloomberg report about the Justice Department joining a lawsuit against another hospice operator may be contributing to weakness in Chemed (CHE -1.9%) shares. DOJ and the Department of Health and Human Services are already investigating Chemed’s Vitas Healthcare, for “an extensive scheme” to defraud the government of “hundreds of millions of dollars." Comment! [Healthcare, On the Move]
Wednesday, November 16, 2011, 9:51 AM Shares of Chemed (CHE -7.9%) trade lower after a whistleblower accuses the firm of an extensive Medicare HMO scheme aimed at defrauding the government. The allegations were unveiled in a lawsuit filed in a federal case against the company. Comment! [Healthcare, On the Move]

ltfinger
Returning Downgrades (5/3/13): $ADNC, $AGNC, $ATHN, $CHE, $CVD, $EQR, $LNKD, $NTI, $SCO, $TDC, $TLT, $TMF
May 6, 9:34 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE
May 3, 11:13 AM
Reply (8)

• !Report Abuse
View all 8 replies
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings.
May 6, 10:44 AM
• !Report Abuse
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.
May 6, 10:46 AM
• !Report Abuse
Add a reply...

140 characters

Andrew Shapiro
http://on.wsj.com/1008hEQ U.S. Sues Chemed for Vitas' False Medicare Billings Costing 'Tens of Millions of Taxpayer $CHE
May 3, 11:04 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Daniel Long
2 stocks hitting 10 yr highs in our most Undervalued Ind-Home Health Care, in most Overvalued Sec-Healthcare $ADUS $CHE http://bit.ly/Xxbb1g
Feb 20, 3:08 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
7 Undervalued Small Caps Pulling In Big Profits http://bit.ly/QrWAmH $CHE $CTB $DENN $GNRC $SAVE $SMP $VCLK @ZetaKap
8/28/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
http://1.usa.gov/ODEh9T Do #Chemed's #Hospice regulatory subpoenas infer additional risk for #Gentiva's Hospice operations? $CHE $GTIV
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
Do Chemed's VITAS Hospice regulatory subpoenas infer additional risk for Gentiva's Hospice operations? $CHE $GTIV
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL regulatory matters - separate July 2012 FLA subpoena for info from 01/2007 too $CHE #hospice
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL - regulatory matters - subpoena from OIG for info from 01/2007 to 6/2012 period $CHE #hospice
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
Chemed 10-CTL released with updated regulatory matters language; issued subpoena from OIG for info from 01/2007 to 6/2012 period $CHE
8/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE
May 3, 11:13 AM
Reply (8)

• !Report Abuse
View all 8 replies
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings.
May 6, 10:44 AM
• !Report Abuse
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.
May 6, 10:46 AM
• !Report Abuse
Add a reply...

140 characters

CHE Chemed Corporation

CHE

Chemed Corporation